EMS Chemie rises on core profit margins beat, confirms FY guidance

** Shares in EMS Chemie EMSN rise 2.2% after the Swiss chemical company posted its core profit margins above expectations, despite lower H1 sales

** EMS posts H1 EBITDA at 323 million Swiss francs ($405.58 million), with a margin of 31.7%, compared to 319 million and 29.4% last year

** Its H1 EBIT amounts to 296 million Swiss francs with a margin of 29% vs 291 million and 26.8% in 2024

** "H1 sales lower than expected. This was compensated by clearly improved margins, which are the highlight of the set of figures," Vontobel says, citing margins came in ahead of market expectations

** "We see a certain risk in potential U.S. tariffs on Swiss products, but in general, we see favorable long-term growth trends in EMS' key markets," it adds

** The company posted H1 sales at 1.02 billion Swiss francs vs 1.09 billion a year earlier, and confirmed its FY guidance

($1 = 0.7964 Swiss francs)